After excluding 684 patients with insufficient transferrin saturation data, the remaining 1040 patients experienced 103 events, including 35 hospitalizations for congestive heart failure, 18 for cerebrovascular disease, 12 for angina pectoris, and 8 for ischemic heart disease requiring invasive intervention. This evidence concerns the gene TF and cerebrovascular disorder.